A Long-term Follow-up Study of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Oct 2017
At a glance
- Drugs GSK 3277511 (Primary)
- Indications Respiratory tract disorders
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 28 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 24 Jul 2017 Status changed from not yet recruiting to recruiting.
- 30 Jun 2017 New trial record